Clinical Trials Browser

Phase EARLY_PHASE1 × Recruiting × INDUSTRY × Clear all

NCT07205315 2026-05-27

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

Phase EARLY_PHASE1 Recruiting

Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Hemolytic, Autoimmune, Burkitt Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT06097962 2026-05-20

Safety and Efficacy of NK510 to Treat NSCLC

Phase EARLY_PHASE1 Recruiting

Pleural Effusion, Malignant

NCT07595237 2026-05-19

A IIT Study of 177Lu-DOTA-SNA040

Phase EARLY_PHASE1 Recruiting

GastrointestinalOther solid neoplasm

Advanced Solid Tumors (Such as Gastric Cancer)

NCT07597772 2026-05-19

Preliminary Trial of SNA014 for Pancreatic Cancer

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06400485 2026-05-18

AMT-676 in Patients With Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06736275 2026-05-15

A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Cachexia

NCT05245058 2026-05-05

SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

HER2-positive Advanced Solid Tumors

NCT07561437 2026-05-01

NK521 in the Treatment of Malignant Ascites Associated With Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT07468708 2026-04-29

The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer

Phase EARLY_PHASE1 Recruiting

Prostatic Neoplasms

NCT07505771 2026-04-06

A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer

Phase EARLY_PHASE1 Recruiting

Solid Malignancies

NCT07033689 2026-04-03

Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07505069 2026-04-01

Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumors

NCT07376642 2026-03-30

A Phase I/IIa, Open-label, Single-center, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of IMV101 as a Single Agent in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Phase EARLY_PHASE1 Recruiting

Lymphoma, B-Cell

NCT07493135 2026-03-30

A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma

Phase EARLY_PHASE1 Recruiting

Multiple Myeloma

NCT07487597 2026-03-23

Functionally Enhanced ALPP-Targeted Engineered T Cells in Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT07274813 2026-03-03

A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasmThoracic

Advanced/Metastatic Solid Tumors

NCT06305962 2026-02-19

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Phase EARLY_PHASE1 Recruiting

BreastDermatologicGynecologicHead & NeckThoracic

Turcot syndrome, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT07414316 2026-02-17

A Single-Arm, Open-Label Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06824155 2026-02-11

RAD202

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

HER2 Gene Mutation

NCT07327632 2026-02-04

This is a Multi-Center Study of IBI3026 in Participants With Locally Advanced, Unresectable or Metastatic Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT07378436 2026-01-30

A Clinical Study of GK02 in Malignant Ascites

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Stomach Neoplasms

NCT07338604 2026-01-14

Clinical Study of UTAA07 Injection in the Treatment of Hematologic and Lymphatic Systemic Malignancies

Phase EARLY_PHASE1 Recruiting

Hematolymphoid Malignancies

NCT07336823 2026-01-13

JY232(JY232) Injection in Relapsed/Refractory Multiple Myeloma

Phase EARLY_PHASE1 Recruiting

Multiple Myeloma

NCT07328087 2026-01-09

COLONYVAQ™-CRC

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT07312630 2025-12-31

Clinical Study of LV009 Injection for the Treatment of Relapsed/Refractory CD19-Positive Hematologic and Lymphoid Malignancies

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07131254 2025-12-30

A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in Adult Participants With Relapsed/Refractory CD19-positive B-cell Malignant Hematological Tumors

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT06645808 2025-12-29

VARTUTRACE

Phase EARLY_PHASE1 Recruiting

BreastCNSGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Chondrosarcoma, Colonic Neoplasms, Esophageal Neoplasms, Glioblastoma, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Sarcoma, Osteosarcoma, Stomach Neoplasms

NCT04960072 2025-12-23

A Study of GC101 TIL in r/r Gastrointestinal Tumors (10hospital)

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Digestive System Neoplasms

NCT06828328 2025-12-23

A Study of GC203 TIL in PDCA (RJ)

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06488950 2025-12-16

A Study of TIL in Advanced Solid Tumors (DFGD)

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT04943913 2025-12-11

Study of GC101 TIL in Brain Glioma (Soochow2)

Phase EARLY_PHASE1 Recruiting

Glioma

NCT04967833 2025-12-11

A Study of GC101 TIL in Advanced Solid Tumors (TR)

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT05098171 2025-12-11

A Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital)

Phase EARLY_PHASE1 Recruiting

Advanced Gynecologic Tumors

NCT05098184 2025-12-11

A Study of GC101 TIL in Advanced Melanoma (10hospital)

Phase EARLY_PHASE1 Recruiting

Advanced Melanoma

NCT05098197 2025-12-11

A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Advanced Liver Cancers

NCT05142475 2025-12-11

A Study of GC101 TIL in Advanced Breast Cancer (10hospital)

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms

NCT07077616 2025-12-08

TAMAVAQTM

Phase EARLY_PHASE1 Recruiting

Glioma

NCT07246304 2025-11-24

TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC

Phase EARLY_PHASE1 Recruiting

Small Cell Lung Carcinoma

NCT06446128 2025-08-21

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)

Phase EARLY_PHASE1 Recruiting

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT06822998 2025-08-17

HF50

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06700070 2025-08-11

A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors

Phase EARLY_PHASE1 Recruiting

BreastHead & Neck

Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Neoplasms

NCT06092047 2025-05-16

UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.

Phase EARLY_PHASE1 Recruiting

CD19-positive Relapsed or Refractory B-cell Malignancies

NCT06532630 2025-02-28

Anti-CD19-CAR-T Cells in Subjects With Relapsed/Refractory B Cell Malignancies

Phase EARLY_PHASE1 Recruiting

B-Cell Malignancy

NCT06366451 2025-01-20

PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCC

Phase EARLY_PHASE1 Recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT05651178 2025-01-07

Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System Leukemia/Lymphoma Patients

Phase EARLY_PHASE1 Recruiting

Lymphoma, Recurrence

NCT06760260 2025-01-07

Evaluation of the Safety and Efficacy of Human CI-135 (FLT3) Targeted CAR-T Cells Injection for Subjects with Relapsed/Refractory Acute Myeloid Leukemia

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06209606 2024-12-17

Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma

Phase EARLY_PHASE1 Recruiting

Multiple Myeloma

NCT06732232 2024-12-13

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma

Phase EARLY_PHASE1 Recruiting

Multiple Myeloma, Recurrence

NCT06697665 2024-11-20

An Exploratory Clinical Study to Evaluate the Safety, Tolerability, Immune Response and Preliminary Efficacy of LM103 Injection in Combination With PD-1 in Patients With Advanced Solid Tumours

Phase EARLY_PHASE1 Recruiting

Solid Cancer

NCT06695689 2024-11-19

An Investigator-initiated Clinical Study of LM303 Injection for the Treatment of Advanced Solid Tumours

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor